Literature DB >> 21222655

Impaired resistance artery function in patients with end-stage renal disease.

Natallia Luksha1, Leanid Luksha, Juan Jesús Carrero, Folke Hammarqvist, Peter Stenvinkel, Karolina Kublickiene.   

Abstract

We investigated an effect of uraemia on structural and functional features of human resistance vasculature. Arteries (≈ 200 μm) isolated from subcutaneous fat biopsies obtained from 35 ESRD (end-stage renal disease) patients starting peritoneal dialysis and 30 matched controls were studied using isolated small artery bioassays. Flow-mediated dilatation was attenuated in ESRD patients compared with controls. NO (nitric oxide) contribution to flow was lacking in ESRD patients, but present in the controls. ADMA (asymmetrical dimethyl L-arginine) levels were higher in the ESRD group compared with the control group. Dilatation in response to acetylcholine was reduced in ESRD patients compared with controls, but response to NO donor was similar. Expression of nitrotyrosine and heat shock proteins 70 and 27, but not 90, was increased in arteries from ESRD patients compared with controls. Arterial remodelling was absent in ESRD patients. There was no difference between the groups in myogenic tone, vascular reactivity or sensitivity to several vasoconstrictors. Arterial distensibility, reflecting passive properties of the vascular wall, was reduced in ESRD patients compared with controls. Exclusion of ESRD patients with diabetes and/or cardiovascular disease from analyses had no influence on the main findings. Thus we propose that uraemia has a strong impact on endothelial function and passive properties of the arterial wall of human peripheral resistance vasculature. The reduced contribution of NO to flow stimulus via enhanced nitrosative stress and higher plasma concentrations of ADMA may suggest potential mechanisms behind endothelial dysfunction in the resistance peripheral circulation in ESRD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21222655     DOI: 10.1042/CS20100277

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  12 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Vasculoprotective Effects of Dietary Cocoa Flavanols in Patients on Hemodialysis: A Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Tienush Rassaf; Christos Rammos; Ulrike B Hendgen-Cotta; Christian Heiss; Werner Kleophas; Frank Dellanna; Jürgen Floege; Gerd R Hetzel; Malte Kelm
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-17       Impact factor: 8.237

3.  Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.

Authors:  Anna Witasp; Mikael Rydén; Juan Jesús Carrero; Abdul Rashid Qureshi; Louise Nordfors; Erik Näslund; Folke Hammarqvist; Samsul Arefin; Karolina Kublickiene; Peter Stenvinkel
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

4.  Defining uremic arterial functional abnormalities in patients recently started on haemodialysis: combined in vivo and ex vivo assessment.

Authors:  Adil M Abushufa; Mohamed T Eldehni; Aghogho Odudu; Philip D Evans; Saoirse E O'Sullivan; Chris W McIntyre
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

5.  Long chain n-3 polyunsaturated fatty acids and vascular function in patients with chronic kidney disease and healthy subjects: a cross-sectional and comparative study.

Authors:  Morten Borg; My Svensson; Johan V Povlsen; Erik B Schmidt; Christian Aalkjær; Jeppe H Christensen; Per Ivarsen
Journal:  BMC Nephrol       Date:  2016-11-21       Impact factor: 2.388

6.  Erythropoietin therapy improves endothelial function in patients with non-dialysis chronic kidney disease and anemia (EARNEST-CKD): A clinical study.

Authors:  Jina Lim; Chung Jo Yu; Hoon Yu; Sang Jin Ha
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

Review 7.  Cardiovascular risk in pediatric-onset rheumatological diseases.

Authors:  Julie Barsalou; Timothy J Bradley; Earl D Silverman
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

8.  Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease.

Authors:  Leanid Luksha; Peter Stenvinkel; Folke Hammarqvist; Juan Jesús Carrero; Sandra T Davidge; Karolina Kublickiene
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

9.  Hemodynamics and function of resistance arteries in healthy persons and end stage renal disease patients.

Authors:  Morten K Borg; Per Ivarsen; Emil Brøndum; Johan V Povlsen; Christian Aalkjær
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

10.  Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis.

Authors:  Chiz-Tzung Chang; Guei-Jane Wang; Chin-Chi Kuo; Ju-Yi Hsieh; An-Sean Lee; Chia-Ming Chang; Chun-Cheng Wang; Ming-Yi Shen; Chiu-Ching Huang; Tatsuya Sawamura; Chao-Yuh Yang; Nicole Stancel; Chu-Huang Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.